Rasburicase Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 1.5 mg/1.5 mL (1.5 mg vial)

Reference Brands: Elitek® (US & EU)

Category: Oncology Cancer Care

Rasburicase is available in Injection and strengths such as 1.5 mg/1.5 mL (1.5 mg vial). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Rasburicase is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Rasburicase can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Rasburicase is an enzyme therapy used for the prevention and treatment of tumor lysis syndrome (TLS) in patients with hematologic malignancies, such as leukemia and lymphoma. It is a recombinant urate oxidase that helps lower elevated uric acid levels, which can occur after chemotherapy. Available under the brand Elitek®, Rasburicase is marketed in 1.5 mg vials for injection in the US and EU. Manufactured under GMP-compliant standards, it is a vital product for oncology B2B pharma distributors and is supplied for use in hospitals and treatment centers globally.